{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"126","value":"1052"},{"groupId":"OG001","spread":"126","value":"1052"},{"groupId":"OG002","spread":"180","value":"513"},{"groupId":"OG003","spread":"76","value":"517"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"5"}],"units":"Participants"}],"description":"Maximum observed plasma concentration","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Cohort 1: Defactinib 400 mg BID for 12 days","id":"OG000","title":"Cohort 1"},{"description":"Cohort 2: Defactinib 400 mg BID for 35 days","id":"OG001","title":"Cohort 2"},{"description":"Defactinib 400 mg for 21 days","id":"OG002","title":"Cohort 3 (Fed)"},{"description":"Defactinib 100 mg BID for 21 days","id":"OG003","title":"Cohort 4 (Fasted)"}],"paramType":"GEOMETRIC_MEAN","reportingStatus":"POSTED","timeFrame":"0-24 hours","title":"Evaluate the Pharmacokinetics of VS-6063 (Defactinib), CMax","type":"PRIMARY","unitOfMeasure":"ng/mL"}